PubMed Health⌕ Search

Biomedical subjects

N V Ermakov

Publications and source records attributed to N V Ermakov.

38 records · Page 3Linked to original sources

[Hemoglobin M Saskatoon alpha 2 beta 2 63 (E7) His--Tyr. Structural identification, hemichrome formation and proteolytic degradation].

During examination of the patient with methemoglobinemia of unclear ethiology abnormal Hb was found in the blood hemolysate. The primary structure determination allowed to identify the variant as Hb M Saskatoon with alpha 2 beta 2 63 (E7) His leads to Tyr substitution, that is the first known case of Hb M Saskatoon bearing in the Soviet Union. From the investigation of some physico-chemical properties it was concluded that not only the distal histidine can play the role of the sixth endogenous ligand at the hemichrome formation. The proteolytic degradation of met Hb M Saskatoon showed, that a shift of the distal residue (E7) to the heme ligand position does not itself lead to a considerable increase of the conformational lability of the protein as in the case of a few hemichrome forms.

Amino Acids↗

[Use of endothelial protector Softel in surgery of the anterior eye segment].

Endothelium protector SOFTEL is developed by Ekran firm and Institute of Eye Diseases, Russian Academy of Medical Sciences. The drug was used in 157 patients aged 28-79 years. Perforating keratoplasty for corneal leukoma and keratoconus was carried out in 46 patients, cataract extraction with implantation of intraocular lens (IOL) in 94, and cataract extraction without IOL implantation in 17 patients. Two patients developed slight hypertension in the postoperative period, which resolved within 24 h, and four patients developed moderate corneal edema persisting for 1-2 days postoperation. The protective effect of softel is compatible with that of its foreign analog Healon. The drug is effective in cataract extractions with IOL implantation and perforating keratoplasty.

Adult↗